Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0000950170-25-108850·Oric Pharmaceuticals, Inc.
Schedule 13D ownership disclosure
ORIC Pharmaceuticals Inc
Common Stock, $0.0001 par value per share · CUSIP: 68622P109
Event date: 2025-08-12
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- SR One Capital Management, LLCReported CIK 0001853723
Shares: 4,615,384 · Class: 4.75%
- SR One Capital Opportunities Fund I, LP
Shares: 2,382,064 · Class: 2.45%
- SR One Capital Opportunities Partners I, LP
Shares: 2,382,064 · Class: 2.45%
- AMZL, LP
Shares: 1,538,461 · Class: 1.60%
- SR One Capital SMA Partners, LP
Shares: 1,538,461 · Class: 1.60%
- SR One Capital Fund II Aggregator, LP
Shares: 694,859 · Class: 0.73%
- SR One Capital Partners II, LP
Shares: 694,859 · Class: 0.73%
- Simeon George
Shares: 4,615,384 · Class: 4.75%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-108850
- Form type
- SCHEDULE 13D/A
- Filer
- Oric Pharmaceuticals, Inc.
- CIK
- CIK 1796280
- Filed
- Aug 14, 2025
- Reporting period
- Aug 12, 2025
- Description
- Schedule 13D beneficial ownership